Characteristic | Data |
Age (y) | 68 (56–81) |
Initial Gleason score | 9 (6–9) |
PSA at time of scan (ng/mL) | 473 (1.7–2,792) |
WHO performance score | 0 (0–2) |
Length (cm) | 181 (171–191) |
Weight (kg) | 92 (64–119) |
Prior treatment | |
Androgen deprivation therapy | n = 7 (88%) |
Docetaxel | n = 7 (88%) |
Enzalutamide/abiraterone | n = 5 (63%) |
Qualitative data are expressed as numbers followed by percentages in parentheses; continuous data are expressed as median followed by range in parentheses.
WHO = World Health Organization.